<DOC>
	<DOCNO>NCT00788229</DOCNO>
	<brief_summary>The purpose study determine whether artificial tear safe effective treatment Dry Eye Syndrome .</brief_summary>
	<brief_title>Efficacy Safety Study ATs Patients With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<criteria>Male female adult age 18 year . Subjects diagnose dry eye syndrome eye one eye , keratoconjunctivitis sicca ( KCS ) , least 3month history diagnose dry eye syndrome due Sjögren syndrome . Subjects must agree discontinue artificial tear Screening 2 week Subjects must discontinue lens wear one week Screening agree wear contact lenses entire study . Subjects take Restasis® eligible inclusion use Restasis® 4 week prior Screening Subjects must provide sign informed consent prior participation studyrelated procedure Subjects dose Participate clinical trial within 6 month prior Screening . Pregnancy lactation . Females childbearing potential use systemic contraception , postmenopausal ( ≥ 1 year ) , surgically sterilize . Ocular surgery ( type , include laser surgery ) ocular trauma within 4 month prior Screening . Any active inflammation eye due KCS Other disease characteristic judge investigator incompatible assessment need study reliable instillation study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Dry Eye Syndromes</keyword>
	<keyword>Keratoconjunctivitis Sicca</keyword>
	<keyword>artificial tear</keyword>
	<keyword>carboxymethylcellulose sodium</keyword>
	<keyword>sodium hyaluronate</keyword>
</DOC>